MHV-370

N/A

Report date: 2023/09/26 13:41:41
NME

Base Information

Drug NameMHV-370
Drug Alias NameMHV-370
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 8 antagonists
TargetsToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsMixed Connective Tissue DiseaseLupus Erythematosus, SystemicSjogren's Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanPolandHungary +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharmaceuticals Corp
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNovartis Pharma AgNovartis Pharmaceuticals Corp
Inactive CompaniesChina Novartis Institutes For Biomedical Research Co Ltd
Active IndicationsMixed Connective Tissue DiseaseLupus Erythematosus, SystemicSjogren's Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A